Genetically engineered mosquitoes resist dengue fever virus

When a mosquito bites someone infected with DENV, the virus needs to complete its lifecycle in the mosquito's gut, eventually infecting its salivary glands, before it can infect another person. Previous studies have shown that mosquitoes rely on a molecular pathway dubbed JAK/STAT to try to fight DENV infection and stop this cycle. Proteins known as Dome and Hop are involved in turning on the JAK/STAT when the mosquito is infected with DENV.

In the new work, George Dimopoulos, of Johns Hopkins University, and colleagues genetically engineered Aedes aegypti mosquitoes to turn on expression of either Dome or Hop, in the fatbody tissue, earlier in infection -- immediately after ingesting blood -- and make more of the proteins.

mosquitoes with engineered versions of Dome or Hop that were then infected with DENV had 78.18% (Dome) and 83.63% (Hop) fewer copies of the virus in their guts, as well as significantly less virus in their salivary glands. mosquitoes with the altered genes had normal lifespans, but produced fewer eggs than normal mosquitoes. When the researchers repeated the experiments with Zika virus and chikungunya virus, no impact was seen on infection, suggesting that the importance of the JAK/STAT pathway in the fatbody tissue is unique to DENV.

"It may be possible to achieve improved or total resistance to dengue and other viruses by expressing additional transgenes in multiple tissues that block the virus through different mechanisms," the researchers write. "Recently developed powerful mosquito gene-drive systems, that are under development, are likely to make it possible to spread pathogen resistance in mosquito populations in a self-propagating fashion, even at a certain fitness cost."